Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Silymarin Mitigate Clinical Course of COVID-19 in Patients Admitted to an Internal Medicine Ward With Elevated Liver Enzymes?

NCT04816682 is registered in ClinicalTrials.gov with F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica as lead sponsor.

NCT NCT04816682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04816682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Silymarin Mitigate Clinical Course of COVID-19 in Patients Admitted to an Internal Medicine Ward With Elevated Liver Enzymes?
Lead sponsor
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
Phase
Phase 4
Overall status
Completed
Start date
March 17, 2021
Completion date
December 30, 2021
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, liver diseases